Lawrence P. Guiheen - 09 Feb 2026 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Lawrence P. Guiheen, by Michael A. Goldstein as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
09 Feb 2026
Net transactions value
$0
Form type
4
Filing time
11 Feb 2026, 21:00:11 UTC
Previous filing
11 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Guiheen Lawrence P. Director C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY /s/ Lawrence P. Guiheen, by Michael A. Goldstein as Attorney-in-fact 11 Feb 2026 0001554353

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Award $0 +10,690 +11% $0.000000 105,520 09 Feb 2026 Direct F1, F2
holding ADMA Common Stock 50,990 09 Feb 2026 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Stock Option (Right to Buy) Award $0 +17,730 $0.000000 17,730 09 Feb 2026 Common Stock 17,730 $16.37 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
F2 Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 89,385 shares of common stock owned by the Reporting Person.
F3 Includes 50,990 shares of common stock held in the Lawrence P Guiheen Irrevocable Trust 1.
F4 These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.